Menopause
Real-world safety signals of fezolinetant in women with menopausal vasomotor symptoms: a pharmacovigilance analysis of the WHO VigiAccess database
Study in peopleInterventions
Neurobiology of Disease10 Oct 2026

Research Square10 Oct 2026

PNAS10 Oct 2026

Aging Cell9 Oct 2026
